$14.8 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 116 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 55.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Buy | ALLERGAN PLC | $1,527,448,000 | +45.6% | 7,990,000 | +28.1% | 10.31% | +30.1% |
| SPY | Buy | SPDR S&P 500 ETF TRput | $1,411,356,000 | +43.9% | 4,385,000 | +32.6% | 9.52% | +28.5% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $792,504,000 | +29.1% | 2,400,000 | +1.3% | 5.35% | +15.4% |
| IAC | Buy | IAC INTERACTIVECORP | $514,786,000 | +62.0% | 2,066,500 | +41.8% | 3.47% | +44.8% |
| FIS | Buy | FIDELITY NATL INFORMATION SV | $484,834,000 | +19.5% | 3,485,757 | +14.1% | 3.27% | +6.8% |
| WAB | Sell | WABTEC CORP | $394,383,000 | -12.5% | 5,069,187 | -19.2% | 2.66% | -21.8% |
| ANTM | Buy | ANTHEM INC | $377,538,000 | +47.9% | 1,250,000 | +17.6% | 2.55% | +32.2% |
| GOOG | Buy | ALPHABET INCcap stk cl c | $367,551,000 | +20.6% | 274,903 | +9.9% | 2.48% | +7.8% |
| SMH | New | VANECK VECTORS ETF TRUSTput | $354,232,000 | – | 2,505,000 | +100.0% | 2.39% | – |
| MSFT | Buy | MICROSOFT CORP | $344,699,000 | +75.3% | 2,185,790 | +54.6% | 2.33% | +56.6% |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $331,355,000 | +14.0% | 683,093 | -3.1% | 2.24% | +1.9% |
| CI | Buy | CIGNA CORP NEW | $306,735,000 | +90.1% | 1,500,000 | +41.1% | 2.07% | +70.0% |
| IQV | Sell | IQVIA HLDGS INC | $286,568,000 | -27.3% | 1,854,687 | -29.8% | 1.93% | -35.1% |
| V | Buy | VISA INC | $286,070,000 | +28.4% | 1,522,460 | +17.5% | 1.93% | +14.7% |
| MDCO | New | MEDICINES CO | $281,576,000 | – | 3,315,000 | +100.0% | 1.90% | – |
| CRM | New | SALESFORCE COM INC | $280,534,000 | – | 1,724,880 | +100.0% | 1.89% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $277,166,000 | – | 853,160 | +100.0% | 1.87% | – |
| PLYA | PLAYA HOTELS & RESORTS NV | $257,098,000 | +7.3% | 30,606,930 | 0.0% | 1.74% | -4.1% | |
| PANW | Buy | PALO ALTO NETWORKS INC | $256,321,000 | +106.2% | 1,108,416 | +81.7% | 1.73% | +84.2% |
| EQIX | Buy | EQUINIX INC | $243,008,000 | +13.4% | 416,323 | +12.0% | 1.64% | +1.3% |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $240,203,000 | -34.0% | 1,132,500 | -47.9% | 1.62% | -41.0% |
| ZAYO | Buy | ZAYO GROUP HLDGS INC | $236,313,000 | +41.0% | 6,820,000 | +37.9% | 1.60% | +26.0% |
| ABBV | Buy | ABBVIE INC | $221,350,000 | +192.3% | 2,500,000 | +150.0% | 1.49% | +161.2% |
| SHW | Sell | SHERWIN WILLIAMS CO | $214,611,000 | -13.3% | 367,775 | -18.3% | 1.45% | -22.5% |
| FB | Sell | FACEBOOK INCcl a | $211,472,000 | -12.9% | 1,030,313 | -24.4% | 1.43% | -22.2% |
| INFO | Sell | IHS MARKIT LTD | $206,726,000 | -13.5% | 2,743,550 | -23.3% | 1.40% | -22.8% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $177,934,000 | +19.2% | 1,279,000 | -17.5% | 1.20% | +6.5% |
| SPGI | Sell | S&P GLOBAL INC | $174,856,000 | -14.2% | 640,382 | -23.1% | 1.18% | -23.4% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $173,000,000 | +57.8% | 6,250,000 | +3.7% | 1.17% | +41.1% |
| GD | Sell | GENERAL DYNAMICS CORP | $173,064,000 | -4.5% | 981,365 | -1.0% | 1.17% | -14.7% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $166,997,000 | +38.4% | 1,450,000 | -3.3% | 1.13% | +23.7% |
| MYOK | Buy | MYOKARDIA INC | $149,414,000 | +41.1% | 2,050,000 | +1.0% | 1.01% | +26.0% |
| EXEL | Buy | EXELIXIS INC | $132,150,000 | +327.0% | 7,500,000 | +328.6% | 0.89% | +281.2% |
| TRU | Buy | TRANSUNION | $130,792,000 | +28.5% | 1,527,771 | +21.7% | 0.88% | +14.8% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $108,115,000 | +41.2% | 1,750,000 | +37.3% | 0.73% | +26.3% |
| XLRN | Sell | ACCELERON PHARMA INC | $106,040,000 | +11.8% | 2,000,000 | -16.7% | 0.72% | 0.0% |
| EFX | Buy | EQUIFAX INC | $91,385,000 | +2.3% | 652,189 | +2.7% | 0.62% | -8.6% |
| BRMK | New | BROADMARK RLTY CAP INC | $91,476,000 | – | 7,174,613 | +100.0% | 0.62% | – |
| BMYRT | New | BRISTOL MYERS SQUIBB COright 99/99/9999 | $91,429,000 | – | 30,374,950 | +100.0% | 0.62% | – |
| ZGNX | ZOGENIX INC | $91,228,000 | +30.2% | 1,750,000 | 0.0% | 0.62% | +16.4% | |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $88,440,000 | +191.6% | 4,125,000 | +106.2% | 0.60% | +160.7% |
| AXE | New | ANIXTER INTL INC | $84,538,000 | – | 917,893 | +100.0% | 0.57% | – |
| ZYME | Sell | ZYMEWORKS INC | $77,282,000 | +80.0% | 1,700,000 | -1.8% | 0.52% | +61.1% |
| QGEN | New | QIAGEN NV | $72,805,000 | – | 2,154,000 | +100.0% | 0.49% | – |
| GRFS | GRIFOLS S Asp adr rep b nvt | $72,507,000 | +16.2% | 3,113,222 | 0.0% | 0.49% | +3.8% | |
| BOLD | New | AUDENTES THERAPEUTICS INC | $71,210,000 | – | 1,190,000 | +100.0% | 0.48% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $59,688,000 | – | 1,250,000 | +100.0% | 0.40% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $59,618,000 | -23.8% | 750,000 | -53.5% | 0.40% | -32.0% |
| CCXI | Sell | CHEMOCENTRYX INC | $59,325,000 | +334.6% | 1,500,000 | -25.5% | 0.40% | +288.3% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $59,128,000 | +132.3% | 950,000 | +26.7% | 0.40% | +107.8% |
| FGEN | Buy | FIBROGEN INC | $57,902,000 | +56.6% | 1,350,000 | +35.0% | 0.39% | +40.1% |
| CVS | Sell | CVS HEALTH CORP | $55,718,000 | -1.8% | 750,000 | -16.7% | 0.38% | -12.4% |
| RARX | New | RA PHARMACEUTICALS INC | $55,758,000 | – | 1,188,100 | +100.0% | 0.38% | – |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $54,258,000 | – | 2,750,000 | +100.0% | 0.37% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCcall | $51,616,000 | – | 400,000 | +100.0% | 0.35% | – |
| ARQL | New | ARQULE INC | $50,299,000 | – | 2,520,000 | +100.0% | 0.34% | – |
| Buy | PTC THERAPEUTICS INCnote 3.000% 8/1 | $45,851,000 | +81.9% | 39,676,000 | +64.1% | 0.31% | +62.6% | |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $45,708,000 | +464.6% | 442,222 | +10.6% | 0.31% | +404.9% |
| KRTX | New | KARUNA THERAPEUTICS INC | $45,204,000 | – | 600,000 | +100.0% | 0.30% | – |
| FATE | FATE THERAPEUTICS INC | $44,033,000 | +26.0% | 2,250,000 | 0.0% | 0.30% | +12.5% | |
| PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $41,993,000 | +13.0% | 8,250,000 | +12.2% | 0.28% | +0.7% |
| RDUS | RADIUS HEALTH INC | $41,418,000 | -21.7% | 2,054,486 | 0.0% | 0.28% | -30.0% | |
| TCDA | Buy | TRICIDA INC | $37,740,000 | +144.5% | 1,000,000 | +100.0% | 0.26% | +117.9% |
| CARA | Buy | CARA THERAPEUTICS INC | $37,053,000 | -5.7% | 2,300,000 | +7.0% | 0.25% | -15.8% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $36,095,000 | -31.0% | 500,000 | +34.1% | 0.24% | -38.2% |
| PTCT | PTC THERAPEUTICS INC | $34,917,000 | +42.0% | 726,986 | 0.0% | 0.24% | +26.9% | |
| New | KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $34,430,000 | – | 24,000,000 | +100.0% | 0.23% | – | |
| ZEAL | Sell | ZEALAND PHARMA A Ssponsored adr | $33,525,000 | +30.9% | 1,009,800 | -0.0% | 0.23% | +17.1% |
| CYPRESS SEMICONDUCTOR CORPnote 4.500% 1/1 | $32,443,000 | -0.4% | 18,645,000 | 0.0% | 0.22% | -11.0% | ||
| MLNX | Buy | MELLANOX TECHNOLOGIES LTD | $31,639,000 | +131.0% | 270,000 | +116.0% | 0.21% | +107.8% |
| AVRO | AVROBIO INC | $31,202,000 | +42.6% | 1,550,000 | 0.0% | 0.21% | +27.9% | |
| TIF | New | TIFFANY & CO NEW | $30,071,000 | – | 225,000 | +100.0% | 0.20% | – |
| INST | New | INSTRUCTURE INC | $29,890,000 | – | 620,000 | +100.0% | 0.20% | – |
| NVTA | Buy | INVITAE CORP | $28,228,000 | +12.7% | 1,750,000 | +34.6% | 0.19% | +1.1% |
| VCYT | VERACYTE INC | $27,920,000 | +16.3% | 1,000,000 | 0.0% | 0.19% | +3.9% | |
| STML | Buy | STEMLINE THERAPEUTICS INC | $24,981,000 | +4.3% | 2,350,000 | +2.2% | 0.17% | -6.6% |
| RC | Sell | READY CAP CORP | $24,937,000 | -29.0% | 1,617,170 | -26.7% | 0.17% | -36.6% |
| QTNT | Buy | QUOTIENT LTD | $23,775,000 | +80.0% | 2,500,000 | +47.1% | 0.16% | +60.0% |
| New | INTERCEPT PHARMACEUTICALS INnote 2.000% 5/1 | $23,148,000 | – | 17,500,000 | +100.0% | 0.16% | – | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $22,551,000 | -3.5% | 175,000 | -41.7% | 0.15% | -14.1% |
| PRNB | New | PRINCIPIA BIOPHARMA INC | $21,912,000 | – | 400,000 | +100.0% | 0.15% | – |
| SVRA | Buy | SAVARA INC | $21,616,000 | +132.3% | 4,825,086 | +37.4% | 0.15% | +108.6% |
| AMRN | New | AMARIN CORP PLCcall | $21,440,000 | – | 1,000,000 | +100.0% | 0.14% | – |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $21,317,000 | -7.2% | 350,000 | -37.5% | 0.14% | -16.8% |
| WMGI | New | WRIGHT MED GROUP N V | $21,031,000 | – | 690,000 | +100.0% | 0.14% | – |
| HRTX | New | HERON THERAPEUTICS INC | $20,563,000 | – | 875,000 | +100.0% | 0.14% | – |
| CY | Sell | CYPRESS SEMICONDUCTOR CORP | $19,597,000 | -65.9% | 840,000 | -65.9% | 0.13% | -69.7% |
| NLOK | New | NORTONLIFELOCK INC | $18,374,000 | – | 720,000 | +100.0% | 0.12% | – |
| S | Sell | SPRINT CORPORATION | $16,672,000 | -56.7% | 3,200,000 | -48.7% | 0.11% | -61.2% |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $16,309,000 | +41.4% | 1,094,559 | -2.7% | 0.11% | +26.4% |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $15,420,000 | – | 3,000,000 | +100.0% | 0.10% | – |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $15,332,000 | +4.9% | 75,000 | -58.8% | 0.10% | -6.4% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $15,310,000 | – | 500,000 | +100.0% | 0.10% | – |
| LVGO | New | LIVONGO HEALTH INC | $15,036,000 | – | 600,000 | +100.0% | 0.10% | – |
| XGN | Buy | EXAGEN INC | $14,674,000 | +160.7% | 577,699 | +59.0% | 0.10% | +130.2% |
| QURE | Buy | UNIQURE NV | $14,332,000 | +260.8% | 200,000 | +98.2% | 0.10% | +223.3% |
| CLOVIS ONCOLOGY INCnote 1.250% 5/0 | $12,080,000 | +46.2% | 18,801,000 | 0.0% | 0.08% | +32.3% | ||
| LOGM | New | LOGMEIN INC | $11,167,000 | – | 130,241 | +100.0% | 0.08% | – |
| PTGX | PROTAGONIST THERAPEUTICS INC | $10,575,000 | -41.3% | 1,500,000 | 0.0% | 0.07% | -47.8% | |
| OPTN | New | OPTINOSE INC | $8,298,000 | – | 900,000 | +100.0% | 0.06% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $8,059,000 | – | 354,082 | +100.0% | 0.05% | – |
| GCVRZ | Buy | SANOFIright 12/31/2020 | $7,910,000 | +103.2% | 9,195,584 | +34.7% | 0.05% | +82.8% |
| GOSS | Buy | GOSSAMER BIO INC | $7,815,000 | +362.2% | 500,000 | +396.5% | 0.05% | +307.7% |
| DERMTECH INC | $7,631,000 | +121.4% | 615,385 | 0.0% | 0.05% | +100.0% | ||
| ABEO | New | ABEONA THERAPEUTICS INC | $6,540,000 | – | 2,000,000 | +100.0% | 0.04% | – |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $6,343,000 | -65.4% | 100,000 | -84.6% | 0.04% | -68.8% |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $6,110,000 | +81.4% | 1,000,000 | +23.8% | 0.04% | +64.0% |
| Buy | RADIUS HEALTH INCnote 3.000% 9/0 | $5,787,000 | +407.6% | 6,750,000 | +440.0% | 0.04% | +333.3% | |
| OYST | New | OYSTER POINT PHARMA INC | $5,641,000 | – | 230,800 | +100.0% | 0.04% | – |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $5,513,000 | – | 334,706 | +100.0% | 0.04% | – |
| XRX | New | XEROX HOLDINGS CORP | $4,793,000 | – | 130,000 | +100.0% | 0.03% | – |
| OPK | New | OPKO HEALTH INC | $3,675,000 | – | 2,500,000 | +100.0% | 0.02% | – |
| BRMKWS | New | BROADMARK RLTY CAP INC*w exp 11/15/202 | $2,726,000 | – | 7,174,613 | +100.0% | 0.02% | – |
| ZFGN | ZAFGEN INC | $2,007,000 | +50.2% | 1,808,360 | 0.0% | 0.01% | +40.0% | |
| APTX | Sell | APTINYX INC | $1,397,000 | -40.6% | 408,549 | -39.4% | 0.01% | -50.0% |
| CYCN | Sell | CYCLERION THERAPEUTICS INC | $952,000 | -79.1% | 350,000 | -7.1% | 0.01% | -82.4% |
| IIVI | Exit | II VI INC | $0 | – | -47,687 | -100.0% | -0.01% | – |
| PFNX | Exit | PFENEX INC | $0 | – | -600,000 | -100.0% | -0.04% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -350,000 | -100.0% | -0.10% | – |
| Exit | SOLARCITY CORPnote 1.625%11/0 | $0 | – | -17,370,000 | -100.0% | -0.13% | – | |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -220,000 | -100.0% | -0.16% | – |
| PVTL | Exit | PIVOTAL SOFTWARE INC | $0 | – | -1,430,000 | -100.0% | -0.16% | – |
| SYMC | Exit | SYMANTEC CORP | $0 | – | -1,030,000 | -100.0% | -0.18% | – |
| UBER | Exit | UBER TECHNOLOGIES INCput | $0 | – | -1,102,500 | -100.0% | -0.25% | – |
| NXPI | Exit | NXP SEMICONDUCTORS N V | $0 | – | -325,000 | -100.0% | -0.27% | – |
| BKNG | Exit | BOOKING HLDGS INC | $0 | – | -31,139 | -100.0% | -0.46% | – |
| TMCX | Exit | TRINITY MERGER CORP | $0 | – | -75,000,000 | -100.0% | -0.58% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -4,165,000 | -100.0% | -0.59% | – |
| GWR | Exit | GENESEE & WYO INCcl a | $0 | – | -782,673 | -100.0% | -0.65% | – |
| SE | Exit | SEA LTDsponsored ads | $0 | – | -3,375,000 | -100.0% | -0.79% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -2,375,785 | -100.0% | -0.80% | – |
| BPL | Exit | BUCKEYE PARTNERS L Punit ltd partn | $0 | – | -3,900,000 | -100.0% | -1.21% | – |
| CTXS | Exit | CITRIX SYS INC | $0 | – | -1,900,323 | -100.0% | -1.38% | – |
| AABA | Exit | ALTABA INC | $0 | – | -34,189,499 | -100.0% | -5.03% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -15,569,730 | -100.0% | -11.68% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.